Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000940180-98-000152
Filing Date
1998-02-13
Accepted
1998-02-13 00:00:00
Documents
2
Group Members
ANTHONY B. EVNINANTHONY SUNDAVID R. HATHAWAYKIMBERLEY A. RUMMELSBURGMARK W. BAILEYPATRICK F. LATTERELLRAY A. ROTHROCKTED H. MCCOURTNEYVENROCK ASSOCIATESVENROCK ASSOCIATES II, L.P.
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G SC 13G/A 23826
2 AGREEMENT EX-1 3492
  Complete submission text file 0000940180-98-000152.txt   29789
Mailing Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112
Business Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112 2126495600
VENROCK ASSOCIATES (Filed by) CIK: 0000937889 (see all company filings)

EIN.: 136300995 | State of Incorp.: NY | Fiscal Year End: 1231

Mailing Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Subject) CIK: 0001022622 (see all company filings)

EIN.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47359 | Film No.: 98539981
SIC: 2834 Pharmaceutical Preparations